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Abstract: Antibiotic resistance has increased markedly in Gram-negative bacteria, causing severe
infections intractable with traditional drugs and amplifying mortality and healthcare costs.
Consequently, to find novel antimicrobial compounds, active on multidrug resistant bacteria, is
mandatory. In this regard, cationic antimicrobial peptides (CAMPs)—able to kill pathogens on
contact—could represent an appealing solution. However, low selectivity, hemolytic toxicity and
cost of manufacturing, hamper their massive clinical application. In the recent years—starting from
CAMPs as template molecules—less toxic and lower-cost synthetic mimics of CAMPs, including
cationic peptides, polymers and dendrimers, have been developed. Although the pending issue
of hemolytic toxicity and biodegradability is still left not completely solved, cationic antimicrobial
polymers (CAPs), compared to small drug molecules, thanks to their high molecular weight, own
appreciable selectivity, reduced toxicity toward eukaryotic cells, more long-term activity, stability
and non-volatility. With this background, an updated overview concerning the main manufactured
types of CAPs, active on Gram-negative bacteria, is herein reported, including synthetic procedure
and action’s mechanism. Information about their structures, antibacterial activity, advantages and
drawbacks, was reported in the form of tables, which allow faster consultation and quicker learning
concerning current CAPs state of the art, in order not to retrace reviews already available.
Keywords: antibiotic resistance; Gram-negative bacteria; hemolytic cytotoxicity; membrane disruption;
positively charged polymers
1. Introduction
The increasing replacement of antibiotic-susceptible bacteria (ASB) with antibiotic-resistant
bacteria (ARB) is one of the most concern of microbiologists and over the last two decades, antibiotic
resistance has increased markedly in Gram-negative bacteria and has determined an improvement of
mortality and of healthcare costs [1,2].
Gram-negative bacteria pose a major threat to human health, since they are the most critically
resistant and rapidly spreading bacteria, frequently responsible for severe and often deadly infections,
not only in the general population, but also in the hospital settings or among people with weak or
not yet fully developed immune systems, such as newborns, elderly, people undergoing surgery and
cancer treatment.
Gram-negative bacteria, such as Klebsiella pneumoniae, Acinetobacter baumanni, Pseudomonas
aeruginosa, Burkholderia cepacia and Escherichia coli, are responsible of severe infections including
pneumonia, bloodstream infections, wound or surgical site infections and meningitis in healthcare
settings [3].
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Unfortunately, as very recently outlined by two reports published by the World Health
Organization (WHO) on new antibiotic agents, among the 50 innovative molecules in development,
very few target Gram-negative species [4,5].This findings raise deep concern, especially if considering
a previous report published by WHO in 2017 [6] indicating 12 classes of bacteria that are highly critical
for human health, due to their extraordinary resistant traits, where, in addition to Mycobacterium
tuberculosis, Gram-negative pathogens clearly outnumber the Gram-positive ones. The prevalence of
Gram-negative bacteria over Gram-positive is evident in all the priority groups identified in the report,
such as the “other priority pathogens” group (where A. baumannii, P. aeruginosa and Enterobacteriaceae
are included), the “high priority” group (encompassing Helicobacter pylori, Campylobacter specie,
Salmonella species and Neisseria gonorrhoeae) and the “medium priority” group (that include Hemophilus
influenzae and Shigella species).
Lastly, Gram-negative bacteria, unlike Gram-positive bacteria, are characterized by high and
similar resistance levels, both in Europe and in the United States. In fact, citing the same report [6]:
“when compared to the US data, the European Center for Disease Prevention and Control (ECDC)
surveillance network showed overall lower rates of resistance in Gram-positive bacteria (although
with large differences between countries) and the same worrying rates among Gram-negative bacteria”
These reports, developed by a WHO-led group of independent experts, encourage the medical
research community to develop innovative treatments for these resistant Gram-negative bacteria,
which are spreading rapidly and, more than Gram-positive ones, require urgent solutions.
Incessantly, Gram-negative bacteria build-in abilities, to find new ways to be resilient to drugs
and are also able to pass along genetic materials that allow other bacteria to become drug-resistant as
well [7]. Genotyping and sequencing the whole genome of large groups of isolated clinical bacterial
has allowed the scientists to understand how antibiotic resistance develops and transmits both among
bacteria and patients [8]. The most clinically important resistance phenotypes include carbapenem
resistant Enterobacteriaceae, extensively drug resistant (XDR) P. aeruginosa and XRD A. baumannii.
New Delhi metallo-beta-lactamase 1 (NDM-1) makes bacteria resistant to a broad range of
antibiotics, including those from the carbapenem family, which today are the last line of defense against
antibiotic-resistant bacterial infections.
Antibiotic degradation, antibiotic target modification, modulation of permeability through the
bacterial membrane and structural modifications of bacterial lipopolysaccharide are some of the
established mechanisms of resistance and their knowledge have influenced the development of novel
antibiotics for replacing ineffective beta lactams and have disposed innovative treatment practices in
highly resistant infections [9].
It was established that the traditional antibiotics in the form of single target small molecules or
small hydrophobic drugs, often fail in fighting multidrug resistant bacteria [10] and therefore the
search for identifying structurally different and more effective forms of antimicrobial agents, active
especially against Gram-negative strains is increasingly necessary and urgent.
In this regard, naturally occurring cationic antimicrobial peptides (CAMPs) are a wide
well-performant class of not beta lactams antimicrobial agents [11–13], with a broad spectrum
of action, active on a wide variety of Gram-positive and Gram-negative bacteria, fungi, protozoa
and yeast.
In particular, among CAMPs, polymyxins as colistin (Figure 1) and polymyxin B, that differs by
colistin only for a single amino acid in the peptide ring [14], are cyclic polypeptides produced by some
strains of Bacillus polymyxa, specific to counteract Gram-negative bacteria that nowadays are highly
critical for human health. In fact, polymyxins, although totally ineffective on Gram-positive bacteria [14],
are highly active against most members of Gram-negative strains, including the Enterobacteriaceae
family, counting E. coli, Enterobacter spp., Klebsiella spp., Citrobacter spp., Salmonella spp. and Shigella
spp. and common non fermentative Gram-negative bacteria, such as A. baumannii, P. aeruginosa and
Stenotrophomonas maltophilia [14].
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In  the  last decades, antimicrobial polymers have aroused  increasing  interest among scientific 
community until becoming a “hot” topic as confirmed and highlighted also by the publications trend 
in the years 1990–2020 (Figure 2). 
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The graph in Figure 2 definitely emphasizes how over 30 years, the scientific production and
therefore the research in the field of antimicrobial polymers went from being very limited until 2000,
to growing steadily until it assumed an exponential increase in the last decade, probably hand in
hand to how the concern for the dangers represented by multidrug-resistant Gram-negative bacteria
has grown.
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Mg2+ are  then displaced  from  the negatively  charged phosphate groups of membrane  lipids  and 
consequently LPS is destabilized [14]. 
By these events, CAMPs cause the OM permeabilization, induce impairments in its integrity and 
provoke  pores  formation.  The  increased  permeability  of OM  allows CAMPs  to  reach  the  inner 
cytoplasmic  membrane  (CM),  to  interact  with  its  phospholipids,  to  cause  CM  increasing 
permeabilization,  thus  leading  to  leakage  of  the  cytoplasmic  content  and  to  cell  death  [22–24]. 
2. Number of publications a a function of time that cont in the phrase “antimicrobial polymer”
via Scopus. These data include the cationic antim crobi l polymers literature (the scope of is review).
On this background, in this work, the most important achievements in the field of cationic
antimicrobi l polymers (CAPs) w re reviewed. An updated informa ion oncerning the different
ypes f the indust ialized CAPs active on Gram-negative bacteria that are highl critical for human
health, their tructures, he supposed mechanism of ction and their uses or field of applications, were
reported. In order not to re-propose a simple updat of other reviews alre dy av ilabl , the most part
of information was provided in the form of tables, a more “readers-friendly” tool, which allows faster
consultation and quicker learning of the essential characteristics of the various antimicrobial ge ts
herein discussed.
2. An Overview on CAMPs, the Template Molecules that Inspired the Development of Cationic
Antimicrobial Devices
CAMPs are a class of c tionic peptides active on Gram-positive, Gram-negative bac eria, fungi,
pr tozoa and yeast.
Even if the xact mechanism of action of CAMPs is continuously under debate, the assumption
recognized for long time asserts that concerning Gram-negative bacteria, thanks to their cationic
structure, CAMPs first, interac with the anionic constituents of the outer membrane (OM), as LPS and
phospholipids [22].
In particular, it was reported that concerning polymyxins, the α,γ-diaminobutyric acid (Dab)
residue of the positively charged antimicrobial compounds interacts with the phosphate groups of
the negatively charged lipid A, present in the LPS in OM. The stabilizing divalent cations, Ca2+ and
Mg2+ are then displaced from the negatively charged phosphate groups of membrane lipids and
consequently LPS is destabilized [14].
By these events, CAMPs cause the OM permeabilization, induce impairments in its integrity
and provoke pores formation. The increased permeability of OM allows CAMPs to reach the
inner cytoplasmic membrane (CM), to interact with its phospholipids, to cause CM increasing
permeabilization, thus leading to leakage of the cytoplasmic content and to cell death [22–24].
Summing up, CAMPs act by a “brute-force action” based on a non-specific mechanism, factor that
make resistance less likely to develop [25,26].
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Differently from other antibiotics, CAMPs do not need to cross the CM and enter the cell, to
neutralize bacteria.
The permeabilization of the bacteria membrane by CAMPs action, can be exploited in synergistic
therapies for allowing the associated antibiotic to easily enter the bacterial cell and to reach higher
concentrations inside the cell at low dosage of administration, thus reducing systemic toxicity [27].
Anyway, more specific and targeted mechanisms of action of CAMPs and polymyxins were also
reported, such as the interfering activity with central cellular processes, such as DNA and protein
syntheses, protein folding and cell wall synthesis [28,29].
Moreover, polymyxins possess the so called “endotoxin effect”. In Gram-negative bacteria,
the endotoxin is the lipid A, which is a portion of the LPS and polymyxins have the ability to bind this
endotoxin, thus neutralizing LPS molecules, which will be released during cell lysis [14].
Furthermore, polymyxins inhibit the vital respiratory enzymes, as type II nicotinamide adenine
dinucleotide-quinone oxidoreductases [NDH-2] present in the bacterial CM [14].
Unfortunately, native CAMPs lack specificity and may interact without distinction also with
the membrane of eukaryotic (mammalian) cells, with preference for red blood cells (RBCs), causing
hemolysis and RBCs death, if used for systemic treatment [30].
Poor biocompatibility and hemolytic toxicity may be addressed by chemical modifications, voted
to reduce CAMPs cationic character, but mitigation of cytotoxicity often translated in a reduction
of effectiveness.
In this regard, in a successful study by Jiang et al. (2014), it was reported the substitution of
positively charged residue(s) in the center of the nonpolar face of amphipathic α-helical or cyclic β-sheet
of piscidin 1, a CAMP isolated from fish and dermaseptin S4, isolated from frog, with one or two lysine
residue(s) [29]. By this strategy, a selectivity between eukaryotic and prokaryotic membranes was
achieved, while the antimicrobial activity was maintained and the hemolytic activity and cell toxicity
to mammalian cells was decreased or nullified [30].
The total inactivity of polymyxins on Gram-positive bacteria and the higher efficiency versus
Gram-negative bacteria usually showed by CAMPs, depend on the different composition of the
membranes of the two types of bacteria and on the main mechanism of action of CAMPs, involving
electrostatic interactions with bacterial membranes. If compared to Gram-positive ones, Gram-negative
bacteria own a more complex cell wall, made of two negative phospholipidic membranes and a
surface characterized by a higher density of negative charge, due to the presence of lipopolysaccharide
(LPS), encompassing phosphate and pyrophosphate groups, in the outer membrane (OM). On the
contrary, the negative charge of the unique membrane of Gram-positive bacteria is due only to
phospholipids. LPS is absent and peptidoglycan, polysaccharides and teichoic acids are the other
constituents. Therefore, since CAMPs are amphipathic molecules typically positively charged [31],
are absorbed easier and with stronger electrostatic interactions, which are the first events in the
pathway that leads to bacteria death, on Gram-negative bacteria, rather than on Gram-positive ones.
Unfortunately, despite their considerable activity against multi drug-resistant Gram-negative bacteria,
the clinical application of native CAMPs is limited by their strong toxicity for human cells.
As examples, the use of nisin (Figure 2), which is a polycyclic peptide produced by Lactococcus
lactis bacterium, is restricted to food industry as antimicrobial preservative, while the use of colistin,
after an extensive clinical application for counteracting severe infections from Gram-negative bacteria,
starting from 1970s, was delimited to ophthalmic and topical uses, because of its nephrotoxicity [14].
Systemic or nebulized colistin was continued only for cystic fibrosis patients [14] and its parenteral
administration was adopted as last-resort for alarming infections by multidrug-resistant (MDR)
Gram-negative, such as pneumonia [32].
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For years, it was replaced by innovative and less toxic aminoglycosides, quinolones and β-lactams,
but the increasing incidence of MDR Gram-negative bacteria has coerced scientists to reconsider
systemic polymyxins, since currently are often the only available antibiotic agents effective against
MDR organisms, as the carbapenemase-producing bacteria [14]. Although it seems less probable
to occur than for classical antibiotics, the probable development of bacterial resistance to CAMPs
is an additional distress associated to their massive application [25,26]. Anyway, while traditional
antibiotics, in order to neutralize bacteria, generally targets three organs consists: cell wall, translation
machinery and DNA replication system and each one of these modalities of acting is susceptible to
bacterial resistance, CAMPs are effective also without interfering with specific metabolic processes [25].
By acting with a rapid and non-specific disruptive action on bacteria membranes, they inhibit the
growth of pathogens or kill them simply on contact and before bacteria manage to organize adaptive
processes for becoming resistant in time. As reported, some CAMPs, as tachyplesin II and cecropin
P1 (Figure 3a,b, respectively) proved limited evolution of resistance and, antibiotic-resistant bacteria
display no cross-resistance towards them [33].
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Figure 3. Examples of cationic antimicrobial peptides (CAMPs) not susceptible to develop resistance:
(a) Structure of tachyplesin II; (b) structure of cecropin P1.
Although other issues su h as low peptide stability, costly production and pleiotropic biologic
were raised by skeptics [26], thanks o their broad s ectrum of activity and extreme rapidity in killing
bacteria, compared to chemical antibiotics, much effort was made to find potential novel antibacterial
drug candidates among CAMPs [22,34].
3. Antimicrobial Polymers
Polymers have gained increasing attention by the scientific community as promising materials
to prepare antimicrobial agents because of several advantages. An antibacterial polymeric device,
differently from small drug molecules, could be endowed with more long-term activity, limited residual
toxicity, ch mic l stab lity, non-volatili y and incapacity to permeate through the skin thanks to its
macromolecular st ucture and high molecular weight (MW) [20,21].
The developed antimicrobial polymers can b ivided into three wide families as reported in
Table 1.
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Table 1. Categories of antimicrobial polymer systems.
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In the biocidal polymers the antimicrobial site of biocidal polymers is embodied by the entire
macromolecule, they do not require bioactive repeating units and are necessarily cationic.
The biocidal polymers can be obtained either by the polymerization of cationic monomers not
necessarily active and frequently without antibacterial activity or by functionalizing an inactive
polymeric scaffold with inactive cationic groups to form a cationic macromolecule with antimicrobial
activity due to its high density of positive charge. Biocidal polymers are active because they are
positively charged macromolecules that, miming CAMPs, are able to kill bacteria on contact, by a
disruptive action on their anionic cell membranes [35].
Differently, polymeric biocide derives from the polymerization of antibacterial monomers, which
can be cationic, anionic or uncharged. Therefore, polymeric biocides are not necessarily cationic, they
can also be anionic or neutral, are less active than monomers and act with the same mechanism of
action as monomers. The antibacterial activity resides in the monomeric units and not in the polymer
itself and in some cases, the polymer architecture can even nullify the antibacterial effects of the
monomers. The mechanisms of action of polymeric biocides can therefore be of various types and
do not necessarily interfere with the integrity of the bacterial membranes by destroying them. Lastly,
biocide-releasing polymers consist of non-active polymers loaded with biocide moieties, covalently
linked or physically entrapped, which can be released also in a targeted and/or protracted modality.
In this work, it was reviewed the first class of antimicrobial polymers, i.e., the per se antimicrobial
cationic polymers and in particular, those ones active on Gram-negative bacteria.
The cationic moieties possibly present in cationic antimicrobial polymers (CAPs) are in general
guanidinium, tertiary sulfonium, primary, secondary, tertiary and quaternary ammonium, including
also compounds containing heterocycles such as pyridine, imidazole, etc. with quaternized nitrogen
atoms and quaternary phosphonium groups [36,37].
In order to obtain good materials, the architecture of the designed polymer should be stable in
long-term applications, stable during the required storage time and at the conditions of its targeted
application and should have a low degree of toxicity. Among the developed CAPs, few natural and
semi-synthetic macromolecules and a large variety of synthetic cationic polymers were manufactured.
Since it is reasonable to think that mechanism of action of synthetic CAPs would be similar to
that of CAMPs previously described and considered “membrane active agents”, the main strategies
premeditated to design them, depended on the structural features of the outer envelope of the different
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bacterial cells. Since the scope of this work is to review CAPs active on Gram-negative bacteria, a list
of the some representatives of this class was reported in Table 2, while a brief description of the cell
wall of Gram-negative bacteria was provided in the subsequent Section.














































Pasteurellaceae Pasteurella Pasteurella multocida
Pseudomonadaceae Pseudomonas Pseudomonas aeruginosa
Vibrionaceae Vibrio
Vibrio cholerae (responsible for cholera)
Vibrio fischeri
Stenotrophomonas maltophilia
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4. Structure of Gram-negative Cells Wall
Gram-negative outer envelope is composed of a thin peptidoglycan layer sandwiched between
an inner cytoplasmic cell membrane (CM) and a bacterial outer membrane (OM) (Figure 4).
The fundamental characteristics of the Gram-negative bacteria cell wall are summarized in Table 3.


























Figure 4. Schematic representation of the structure of the cell wall of Gram-negative bacteria.
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As reported in Table 3, the most important characteristic of the outer envelope of the Gram-negative
bacteria cells is a net negative charge, frequently stabilized by the presence of divalent cations such as
Mg2+ and Ca2+. The anionic character is due to LPS present in the OM, to the phospholipids of the
OM and to those of CM, which in turn is composed of a phospholipid bilayer with embedded essential
functional proteins, such as enzymes. CM is semi-permeable and controls the passage of solutes and
metabolites in and out of the cell cytoplasm [38].
The presence in the OM of porin channels, which slow down molecular diffusion and limit the
antibacterial substances diffusion, is considered the reason of the high resistance of Gram-negative
bacteria towards common antiseptics and disinfectants in comparison to Gram-positive [39].
OM and CM represent the primary target for the antibacterial agents, whose main mechanism
of action mimics that of CAMPs and since they are anionic hydrophilic–hydrophobic compartments,
in order to promote their absorption on bacteria, the synthetic antimicrobial polymers were mainly
designed as cationic hydrophilic–hydrophobic macromolecular systems.
5. Antimicrobial Cationic Polymers (CAPs) and their Antibacterial “Brute-force Action”
Several combinations of hydrophilic and hydrophobic polymeric constructions were explored in
order to realize the ideal CAP.
As examples, polymers with controlled MW, precise structure and composition were synthetized
by advanced polymerization techniques, as reversible deactivation radical polymerization (RDRP) or
reversible addition-fragmentation chain transfer polymerization (RAFT).
Block polymers, owing bi-block links, made of a hydrocarbon nonpolar hydrophobic block and of
a cationic one, were developed. Furthermore, random copolymers were achieved by polymerizing
a hydrophobic monomer and a hydrophilic comonomer with a functional group. Hydrophobic
polynorborane-based oligomers and polymers (see Table 5 and Section 7.2) endowed with high
antimicrobial effects against Gram-negative E. coli rather than against S. aureus, were synthetized.
In general, but not always, the developed CAPs are amphiphilic macromolecules and possess
surface-activity properties, the adsorption/absorption ability of surfactants, high binding affinity for
bacterial cells membrane and a proper lipophilicity, that allows them to cause effective damage to the
structural organization and integrity of cell membranes and to lead to cell lysis [20,40,41].
In particular, CAPs like CAMPs, commonly inhibit or kill bacteria immediately on contact by
causing the bacterial cell to burst, through a series of steps [20].
In particular, considering the Gram-negative bacteria of interest of this review, in the first step,
the polymer adsorbs onto the OM of bacterial cell wall, in virtue of an electrostatic interaction and
causes impairments, which translate in an improvement of OM permeability and pores formation.
Second, the polymeric antimicrobial agent diffuses through the cell wall, adsorbs onto the CM and
finally causes CM disruption. The subsequent leakage of cytoplasmic constituents including crucial
cations as K+ leads to the death of the bacteria cell. It is evident that, while small molecule antimicrobial
agents are endowed with a weak adsorption capacity and a good diffusion ability, thanks to their
low MW, CAPs excel at the adsorption steps, that are crucial for disrupting CM and kill the cells
(Table 4) [20].
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Table 4. Comparison between the interaction steps of small molecule antimicrobial agents and cationic
antimicrobial polymers (CAPs).
Step Small MoleculeAntimicrobial Agents CAPs
initial absorption weak strong
diffusion past the cell wall strong weak
binding into the membrane weak strong
disruption and disintegration of the membrane weak strong
Consequently, while the small drugs need to diffuse and enter into bacteria cells to affect
vital processes, CAPs neutralize bacteria on contact without the need of interfering with more fine
metabolic pathways.
Chitosan-based cationic polysaccharides [42,43], polyvinyl-based phosphonium, quaternized
ammonium salts and not quaternized amine polymers [44], insoluble pyridinium-based
polymers [45,46], polymers peripheral functionalized with poly(vinyl-N-pyridinium) salts [47,48],
ε-poly L-lysine (ε-PL) [49], cationic amphiphilic polyacrylates [50] and branched polyethyleneimine
(b-PEI) [51–53] are among others, some examples of the developed classes of natural and synthetic
positively charged polymers endowed with antimicrobial properties. Table 5 reports, as far as possible
complete and updated, a collection of the natural and synthetic CAPs active on Gram-negative bacteria
industrialized in the last years. In particular, in the first column, the simplified structures of the positively
charged polymers can be observed, while in the other columns, the target Gram-negative bacteria
on which compounds were tested and their antibacterial activity is reported. Finally, the advantages
and drawbacks associated to the reported compounds and their uses and/or sectors of application are
also provided. For completeness of information, other details concerning the synthetic strategies and
the mechanisms of action are reported in the text of Sections 6 and 7, including also compounds not
reported in Table 5. A brief description of changes caused by CAPs action in Gram-negative bacteria at
molecular level and of the polymer’s structural factors that could influence their activity and toxicity
are reported in Sections 8 and 9.
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Table 5. Natural and synthetic antimicrobial cationic polymers active on Gram-negative bacteria developed in the last decades.
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6. Natural Positively Charged Antimicrobial Polymers
Among cationic polymers, up today, chitosan and poly(ε-lysine) are the only natural polymers
recognized to possess antimicrobial properties [93].
6.1. Chitosan
Chitosan is a natural cationic polysaccharide deriving from chitin by deacetylation in basic solution
and encompassing in its structure units of β(1→ 4)-2-amido-2-deoxy-D-glucan (D-glucosamine) and
β(1→ 4)-acetoamido-2-deoxy-D-glucan (N-acetyl glucosamine) joined by glycosidic bonds [94–96].
Usually, commercially available contain > 75%–85% deacetylated units and have MW between
50 and 1000 kDa. The degree of deacetylation strongly influence chitosan solubility, its capacity to
interact with polyanions and consequently its antimicrobial effects [97].
In addition, also MW, concentration, physical state (e.g., in solution or in solid state, as fibers,
particles or films) and type of microorganism may influence chitosan activity.
Chitosan can act in two modalities, passively by provoking a reduction of protein adsorption on
bacteria surface that leads to impairing the adhesion capacity of pathogens (in this case, bacteria are
not killed, but only repelled) or actively, killing bacteria on contact.
However, the dominant argument is that chitosan acts principally as an external membrane
disruptor, by interacting electrostatically with Gram-negative bacteria LPSs and by causing the
formation of pores. Once membrane permeability is hopelessly compromised, chitosan can also behave
as penetration material and, if its MW is sufficiently low (MW < 5 kD), can enter into bacteria cells,
bind with microbial DNA and/or mRNA, thus interfering with transcription and translation processes.
A third supposed mechanism is based on the property of chitosan to bind metals as bivalent
cations that stabilized the OM, thus favoring OM destabilization and loss of integrity.
The chitosan capacity of interacting with the negative charges from the bacterial cell surface is
more effective at low pH, that allows the amine groups to be protonated, while the chelation ability is
more efficient at high pH, when the positive metal ions can bound to chitosan, non-protonated amino
groups and the electron pair on the amine nitrogen is available for donation to metal ions [97].
By synthetic quaternization of the nitrogen atoms of the amino groups of chitosan, semisynthetic
chitosan derivatives permanently charged at any pH value were prepared [54,55].
Many methods were proposed for realizing the N-quaternization of the chitosan nitrogen atoms
and several positively charged derivatives were prepared with different amounts of quaternary
ammonium salts moieties.
They are soluble in water and have proved high antimicrobial and antibiofilm activity depending
on the number of cationic groups [54,56–58] and can be eligible for application in pharmaceutic and
biomedical fields as agents against infection by implantation of medical devices.
Chitosan derivatives permanently protonated were prepared by exploiting either the amine
groups or the hydroxyls to insert phosphonium or ammonium salt functions. It is the case of the
chitosan derivatives used by Zhu et al. (2016) [98] (Figure 5a) and by Wang et al. (2016) (Figure 5b) [99].
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Figure 5. Quaternized chitosan derivatives permanently cationic: (a) Chitosan phosphonium salt;
(b) o-quaternary chitosan ammonium salts. R: –CH2Ph (BNQAS–CS); –C12H25 (C12QAS–CS); – C14H29
(C14QAS–CS); – C16H33 (C16QAS–CS); – C18H37 (C18QAS–CS); X: Cl, Br.
N-quaternary phosphonium chitosan derivatives (N–QPCSxy) were prepared by partial amidation of
NH2 moieties of chitosan with 4-(2,5-dioxo-pyrrolidin-1-yloxycarbonyl)-benzyl)-triphenyl-phosphonium
bromides (NHS–QPS).
The best compounds achieved proved water solubility over the pH range of 3 to 12 and
antibacterial activities significantly improved if compared to chitosan and low cytotoxicity. In
particular, the minimum bactericidal concentration (MBC) against E. coli was observed at a dosage of
500 µg/mL, which allowed a red blood cell viability of 74.1% [98].
On the contrary, the chitosan chemical modification proposed by Wang et al., that led to
obtain water-soluble O-quaternary chitosan ammonium salt (QAS–CS) bearing N-methyl-N-R-N-
bis(2-hydroxyethyl)ammonium bromides [R =–benzyl (chloride, BNQAS–CS),–dodecyl (C12QAS–CS),
–tetradecyl(C14QAS–CS),–hexadecyl(C16QAS–CS),–octadecyl(C18QAS–CS)], allowed to achieve
molecules with good antibacterial abilities against Gram-positive bacteria, but bad against
Gram-negative bacteria [99].
6.2. ε-Polylysine (ε-PL)
ε-PL is a cationic polyamide consisting of L-lysine units (n = 25–30), linked together by the
ε-amino and th α-carboxyl groups. ε-PL toxicity is significantly lower than that of CAMPs [49] and
ε-PL has received increasing attention in food industry as preservative additive, thanks to its strong
antimicrobial effects and established safety [49]. In vivo investigations for evaluating acute oral toxicity,
proved that ε-PL is non-toxic at the high dosage of 5 g/kg in rats [49].
Concerning its mechanism of action, Ye et al. (2013) [59] carried out studies to explain ε-PL
antibacterial mechanism of action against E. coli O157:H7 at the molecular level.
The results asserted that, initially the main approach is an electrostatic interaction with OM, then
quickly ε-PL strips of the membrane, causing alteration of cytoplasm distribution, formation of pores
and the onset of structural defects. The increased permeability of membrane favors bacteria penetration
and DNA binding. The disruption of membrane integrity jointed to the detrimental interaction of
ε-PL with genetic material induce oxidative stress by radical oxygen species (ROS) production and
influences various gene expressions leading to bacteria death [60–63].
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7. Synthetic Cationic Antimicrobial Polymers (CAPs)
7.1. Polymers Containing Quaternary Phosphonium and/or Ammonium and/or Guanidinium Groups
Polymeric quaternary ammonium salts (PQASs), quaternary phosphonium salts (PQPSs),
polymeric guanidine (PGSs) and biguanidine salts (PBGSs) are classes of cationic polymer materials
with high potential as antimicrobial agents, due to the high and permanent cationic character of their
quaternary groups [66,75,76,100–103].
7.1.1. Polymers Containing Quaternary Phosphonium and/or Ammonium Groups
PQASs and PQPSs can be obtained either through direct polymerization of monomers already
containing quaternary groups, by incorporating the quaternary moieties into the previously synthesized
polymers or including them by electrostatic interactions with previously synthetized sulfonate polymers.
Polymers with quaternary ammonium or phosphonium salts are materials widely explored as
antimicrobial devices and have proved potent activity [104–107] and effectiveness even against bacteria
that are resistant to other cationic antibacterial agents [108].
Both of them proved to be more active of the corresponding starting small molecules monomers
mainly against Gram-negative bacteria with an effectiveness that resulted enhanced by the increase of
polymeric chain length and by the hydrophobicity of the macromolecules [79,102,109,110].
In general, low MW antimicrobial agents including cationic monomers present several issues
counting environmental toxicity and short-term antimicrobial ability. Their introduction into polymer
molecules achieving biocide polymers as PQASs and PQPSs allows enhancing their efficacy and
selectivity, prolonging their lifetime, minimizing the environmental problems and the residual
toxicity [20].
PQASs and PQPSs, when inserted on surfaces to achieve antimicrobial surfaces able to kill
airborne as well as waterborne microbes, significantly limit bacteria colonization without release of
antimicrobials into the environment.
In addition, they proved higher activity of non-polymeric small antimicrobial drugs because,
while their action consists in impairing the adhesion of bacteria by reducing their contact ability to the
surface (without killing them), PQASs and PQPSs with quaternary ammonium or phosphonium units,
commonly kill bacteria on contact [20,110–114].
Based on the mode of incorporation of quaternary ammonium or quaternary phosphonium
monomers in the polymers, PQASs and PQPSs are classified in two categories: ionically bound or
covalently attached.
Generally, the polymeric materials with active cations electrostatically bound exhibited strong
antibacterial action, thanks to the release in the aqueous environment of the active cationic groups
through an ion exchange mechanism. Differently, in order to exert an antimicrobial action, the class of
compounds where the active cations are covalently linked, requires the contact of the polymer with the
microorganisms [66].
In addition, studies of comparison between PQASs and PQPSs showed that the latter possess
antimicrobial activity higher than that of polymeric quaternary ammonium salts, because of a difference
of electronegativity between nitrogen and carbon atoms and phosphorous and carbon atoms [109].
The reason is attributable to the mechanism of action of the ammonium and phosphonium polymers
that involves as usual, a destructive electrostatic interaction with the bacteria cell wall [66,115].
Concerning Gram-negative bacteria, the results of investigations carried with different
experimental methods in the last decades, supported the hypothesis that antimicrobial polymers bearing
cationic charges on the quaternary ammonium/phosphonium groups, kill bacteria by electrostatic
interaction with the outer membrane (OM) and cytoplasmic membrane (CM), followed by their damage,
cell lysis with release of crucial ions such as potassium [65].
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Due to the difference of electronegativity existing between nitrogen and phosphorous atoms and
the adjacent carbons, in ammonium cation, nitrogen exhibits a negative charge, while in phosphonium,
phosphorous owns a positive charge [116].
Consequently, the stronger polarization and positive charge of phosphorous atoms in PQPSs favor
easier interactions with bacteria wall thus resulting in higher effectiveness [117]. A positively charged
antimicrobial random co-polymer encompassing both kinds of cationic groups was synthetized, via free
radical polymerization (FRP) of acrylamide (AM), diallyl dimethyl ammonium chloride (DADMAC)
and (4-penten-1-yl) triphenylphosphonium bromide (PTBT).
The obtained poly(PTPB-r-AM-r-DADMAC) copolymers, different for the content of PTBT,
in addition to possess antiviral activity, proved to be effective against E. coli but only when the
content in phosphonium monomer was higher than 49%, confirming the higher effectiveness of cation
phosphonium [68].
Later, with a similar procedure, tri-blocks copolymers containing both phosphonium and
ammonium groups were synthetized by AM, tributyl(4-vinylbenzyl)phosphonium (QPM) and
[2-(acryloyloxy)ethyltrimethylammonium chloride (ATC) and were tested for antimicrobial and
antiviral activities.
The results from antibacterial evaluations on S. aureus and E. coli and from viricidal investigations
on influenza virus and adenovirus, demonstrated an excellent antibacterial activity versus both
Gram-positive and Gram-negative bacteria and antiviral activity versus both enveloped and
non-enveloped viruses [67].
In a study by Kougia et al. (2015), a library of homopolymers and copolymers with
quaternary cationic groups either electrostatically bound or covalently linked were prepared.
Furthermore, copolymers, obtained by copolymerizing the cationic monomer vinylbenzyl
dimethylhexadecylammonium chloride (VBCHAM) and either hydrophilic or hydrophobic
comonomers, were synthetized. Even if phosphonium co-polymers were also investigated, the study
mainly focused on quaternary ammonium polymers. The antimicrobial activity, determined as a
function of the contact time at 4 ◦C and 22 ◦C was evaluated against P. aeruginosa, E. coli, S. aureus and
Enterococcus fecalis and eventual relationship between polymer chemical structure and antimicrobial
activity was investigated and discussed [66].
VBCHAM-based copolymers in which acrylic acid (AA) was used as the comonomer and
copolymers presenting both covalently attached and electrostatically bound quaternary ammonium
groups showed the highest antimicrobial activity [66].
In particular, seven cationic macromolecules from this




[P(SSNa-co-VBCHAM)], poly(acrylamide-co-VBCHAM) [P(AA-co-VBCHAM)] and
poly(cetyltrimethylammonium-4-styrene)sulfonate-co-VBCHAM) [P(SSAmC16-co-VBCHAM)]
were reported in Table 5 and the antimicrobial activity of each one against Gram-negative bacteria
were provided.
In order to evaluate practical applications of developed CAPs, it was investigated if their
antimicrobial activity could be maintained when they are embodied in polysulfone (PSF), a polymer
typically used in medical devices. For this experiment, the copolymers P(AA-co-VBCHAM) and
P(SSAmC16-co-VBCHAM) and the homopolymer PSSAmC16, which were the most active, were
entrapped in PSF and the CAPs-enriched PSF-based membrane were essayed. The results confirmed
that the developed antimicrobial materials remain remarkably efficient even when they are incorporated
in PSF membranes [66].
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7.1.2. Polymers Containing Quaternary Guanidinium Groups
Among biguanidinium polymers, poly(hexamethylene biguanide chloride) (PHMB) was the first
antimicrobial polymer whose mechanism of interaction with phospholipid membranes was studied by
Broxton and coworkers on E. coli [77,118].
In particular, it was observed, that the sequence of events during PHMB interaction with the cell
envelope of E. coli involves first, a rapid attraction of PHMB toward the negatively charged bacterial
cell surface, thanks to strong and specific adsorption to phosphate groups of compounds present
in OM. As a consequence, the integrity of the OM is impaired and PHMB is allowed to proceed
and to be attracted to the inner CM, where an additional binding of PHMB to phospholipids occurs.
Consequently, also the integrity of inner membrane begin to impair and if PHMB concentrations are
low, the increment of membrane permeability causes only the loss of potassium ions (K+) and provokes
bacterial stasis. Progressively, higher concentrations of PHMB, increases the extent of the damage and
the size of pores, which allow the loss of larger inorganic species as Cs +, Na +, Li + and inorganic
phosphate. This event leads to a complete loss of membrane functionalities with leak of other essential
cellular components, precipitation of intracellular constituents and bacterial death [77].
The damage to the CM by PHMB is non-specific, immediate and irreversible. Practically, a scenario
similar to that observed for polyvinyl benzyl dimethyl butyl ammonium chloride [65,75].
In regard of growth inhibitory activity and bactericidal activity, PHMB with high MW, i.e., n ≥ 10,
proved to be effective at very low value of MIC and MBC (Table 5), PHMB with 2 > n < 10, proved good
activity (Table 5) while the activity of low MW dimers was questionable. It failed to inhibit motility in
actively growing cultures and did not totally inhibit growth [77].
In a study by Ikeda et al. (1984), it was aroused a concern about the exact evaluation of antimicrobial
activity of biguanidinium compounds in culture medium, because of interfering interactions between
the polymeric biguanides and some culture medium constituents.
In this regard, acrylate monomers with pendant biguanide groups were successfully synthesized
and their homopolymers and copolymers with acrylamide were prepared by radical polymerization
using AIBN as initiator. Evaluated in a clean system, these CAPs showed to be higher effective against
Gram-positive bacteria, rather than on Gram-negative strains, but to be much more active than the
monomeric species [15,65].
Synthetic guanidinium and biguanidinium antimicrobial polymers endowed with a proper
amphiphilic balance, which allows high selectivity for bacteria and good antimicrobial activity, are
considered the best mimics of CAMPs.
In this regard, polyhexamethylene guanidine hydrochloride (PHMG) and three its analogs, i.e.,
polybutamethylene guanidine hydrochloride, polyoctamethylene guanidine hydrochloride (POMG)
and poly(m-xylylene) guanidine hydrochloride, were prepared by reacting guanidine hydrochloride
with the proper di-alkyl amine. The antimicrobial properties of the obtained polymers were
investigated on 370 clinical strains, often involved in nosocomial infections, 96 isolates of which
were antibiotics-resistant. MIC values and MBC data obtained through the time killing essay were
measured and were reported in Table 5 [78].
The best compound was POMG, that provided MIC values (0.5–16 µg/mL) even lower than
those of chlorhexidine digluconate (2–64 µg/mL) against all the 370 antibiotics-susceptible and
antibiotics-resistant clinical strains. Concerning the interest of the present review, POMG displayed
excellent activity (2–16 µg/mL) against several representative of Gram-negative bacteria (Table 5) [78].
The killing curves showed that POMG was bactericidal at 5 µg/mL, concentration that caused an
approximate 6 log10 reduction in the numbers of CFU for clinically isolated P. aeruginosa at 4 h [78].
The broad activity of POMG against antibiotic-resistant bacteria suggests that cationic
guanidine-based polymers possess high potential for the development of novel potent antimicrobials
for clinical applications.
Copolymers with functionalized guanidine pendant groups were prepared by RAFT
polymerization and were evaluated for their antimicrobial activity against some Gram-positive
Polymers 2020, 12, 1195 30 of 47
strains, C. albicans and E. coli, as well as for the hemolytic toxicity [69,74]. While antimicrobial activity
versus Gram-positive bacteria and antifungal effects resulted considerable, antibacterial activity on
E. coli was debatable.
7.2. Polynorborane-based Antimicrobial Polymers
Designed just to mimic CAMPs, polynorboranes (PNBs)-based antimicrobial polymers possess an
amphiphilic structure characterized by having the cationic hydrophilic fragment segregated onto one
region (or face) of the macromolecule and the hydrophobic portion, usually constituted by hydrocarbon
chains, distinctly onto the opposite face.
In this regard, such polymers are called “facially amphiphilic” (FA) and were synthetized by
polymerizing FA norbornene-based monomers, with different protonated groups, such as primary
amine, guanidine or pyridine, located on a side alkyl chain, pending from the nitrogen atom of the
bicyclic norbornane structure (Table 5).
The mechanism of action of these polymers, involves as usually, an initial interaction with OM,
the creation of pores, the insertion of the biocide into the bacteria cell wall, a second electrostatic
interaction with CM, the impairment of its integrity, the progressive increase of its permeability up to
its disruption, loss of cytoplasmic material and bacteria death. The type of counterions, the length
of alkyl side chains and also the molecular charge density strongly influence the activity and the
selectivity of PNBs polymers.
Thanks to their amphiphilic structure, antimicrobial PNBs possess particular ability in inserting
and disrupting the CM of bacteria.
Alkyl hydrophobic norbornene-type polymers and the analogous oxanorbornene-based
hydrophilic macromolecules, containing primary alkyl ammonium groups as cationic moieties were
prepared by Ilker et al. (2004) [86]. The first ones, although very active versus representatives of
Gram-negative bacteria, proved to be not selective for pathogens, thus resulting considerably toxic on
mammalian cells, as established by the vesicle-dye leakage assays (Table 5). On the contrary, the latter
were less cytotoxic, but practically inactive [86].
By random copolymerization of two types of alkyl hydrophobic norbornene monomers, it was
possible to tune the overall hydrophobicity of the polymer achieving CAPs with high selectivity (>100)
and considerable activity against E. coli (MIC [µg/mL, (µM)] = 40, 2.6–3.3).
Similar results were obtained later by Gabriel et al. (2009), for slightly modified oxanorbornene-based
hydrophilic polymers that proved to be endowed with low cytotoxicity and good selectivity, but were
practically inactive (Table 5) [85].
Later a good solution, in terms of preparing compounds with high antimicrobial activity on
bacteria and low hemolytic toxicity on human cells, was to replace the primary ammonium group onto
the side alkyl chain with the guanidinium one [87].
In this regard, a polyguanidinium oxanorbornene (PGON) compound was synthesized from
norbornene monomers via ring-opening metathesis polymerization (ROMP), which in time killing
studies proved to be lethal for bacteria and not only bacteriostatic (Table 5) [87].
A broad library of highly active antimicrobial FA oxanorbornene monomers were prepared
and after ROMP and deprotection, provided several series of polynorbornene-derived polymers
with tunable activity and selectivity [119]. Polyamine oxanorbornene-based antimicrobial random
copolymers, with high hydrophobicity were prepared by performing two different approaches.
One strategy involved the copolymerization of two hydrophobic FA monomers with cationic
primary ammonium groups on side alkyl chains, while the other consisted in copolymerizing
one cationic primary ammonium oxanorbornene monomer and a hydrophobic alkyl amine
oxanorbornene comonomer.
By following the second strategy, a series of copolymers endowed with significant antibacterial
activity and tunable selectivity were prepared [85].
Polymers 2020, 12, 1195 31 of 47
Amphiphilic polyoxanorbornene-based polymers having different quaternary alkyl pyridinium
side chains were synthesized by Eren et al. (2008), but with questionable success [88].
Compounds with a C4 side chain or shorter proved low antimicrobial activity and low hemolytic
toxicity on human red blood cells, while compounds with a side chain longer than C6 proved high
antimicrobial effect, but low selectivity for bacterial over mammalian cells [88].
7.3. Polymers Containing not Quaternized Amine Groups
For years, it was thought that fixing permanent cationic charges on polymers by quaternization of
amine or phosphorus groups could be the best way to achieve polymers with enhanced antimicrobial
effects. To disprove this belief, polymer systems encompassing not quaternary protonated amine
groups were synthetized and their antimicrobial activity was evaluated and compared to that of
N-quaternized analogous derivatives.
In this regard, polystyrene-based polymers, containing tertiary amine groups susceptible of
reversible protonation, exerted bactericidal activity similar to that of the peptide toxin melittin and
somewhat lower activity than that of a potent derivative of the host defense peptide known as
magainin II [71].
For clarity, host defense peptide is another broader term to call CAMPs, which takes into account,
that small cationic amphipathic peptides have strong potential not only as antimicrobials, but also as
antibiofilm agents, immune modulators and anti-inflammatories [120].
The not quaternary compounds, compared to the permanently cationic corresponding
N-quaternized macromolecules, showed far higher antimicrobial activity, suggesting that reversible
N-protonation leads to greater biocidal activity than irreversible N-quaternization [71].
Unfortunately, protonable amine polymers, not exerting their antibacterial activity by a detergent
like membrane disruption mechanism, lacked the selectivity of magainin II and showed high hemolytic
toxicity, mimicking the not selective melittin behavior [71].
Amphiphilic methacrylamide random copolymers, bearing reversibly protonated primary or
tertiary amine groups and encompassing a hydrocarbon hydrophobic side chains, were prepared and
their antimicrobial and hemolytic properties were compared with those of similar macromolecules,
containing quaternary ammonium groups [72].
The not quaternized copolymers owing the primary amine groups proved considerable
antimicrobial activity on E. coli by a membrane-disrupting action [72] and were tunable in order to
achieve CAPs with considerable antimicrobial activity and low hemolytic toxicity (Table 5). Concerning
this, Palermo et al. (2009) demonstrated that antimicrobial activities and biocompatibility depend in a
different manner on the mole fraction of the alkyl side chains, on the length of alkyl groups and on
ionic charge density [121].
As examples, dense cationic charge leads to cytotoxicity, whereas excessive hydrophobicity leads
to hemolysis associated to higher antimicrobial activity and a careful balance of structural features is
necessary for achieving a well-performant antimicrobial device with low level of toxicity.
Analogs macromolecules containing tertiary amine groups proved minor antimicrobial activity
by 100 times and less selectivity, while the quaternized co-polymers, in order to exert acceptable
antimicrobial activity required a greater amount of hydrophobic comonomer and therefore showed
poor selectivity and high hemolytic toxicity [72].
Water-soluble poly(diallylamines) (PDAAs) with cationic charges, thanks to the presence of
pyrrolidine links with secondary or tertiary amine groups, protonated with trifluoroacetic acid,
revealed potent antimicrobial activity against a representative set of bacteria and versus Candida
albicans [79].
In particular, the less active poly(diallylammonium trifluoroacetate) (PDAATFA) derivative with
MW = 24 kDa was bactericidal at 125 µg/mL and bacteriostatic at 62 µg/mL concentrations versus E. coli
at all the conditions adopted for the experiments [79,80].
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The analogs tertiary poly(diallylmethylammonium trifluoroacetate) (PDAMATFA) proved to be
bactericidal versus E. coli even at the lower concentration of 62 µg/mL. PDAATFA and PDAMATFA
derivatives with higher MW (62 kDa and 55 kDa, respectively) proved to be bactericidal also against
P. Aeruginosa, P. Mirabilis and K. Pneumoniae (Table 5) [80,81].
According to what reported in 2009, without however presenting numeric data as proof,
the quaternary hydrophobic polymers of this series and in particular poly(diallyldimethylammonium
chloride) (namely PDADMAC in the cited work) would own week antimicrobial activity [79].
On the contrary, more recent studies showed that PDADMAC, differently named PDDA (poly
(diallyldimethyl) ammonium chloride), displayed the capability of reducing of CFU counting to
one of P. Aeruginosa MDR and K. Pneumoniae KPC+ at minimal concentrations of 1.5 and 0.9 µg/mL,
respectively [81] and excellent microbicidal action against E. coli ATCC 25,922 (5µg/mL) and P. Aeruginosa
(2 µg/mL) at dosage where hemolysis was 0% [80,82–84,122].
The antimicrobial activity against Gram-negative bacteria of PDAA series increases with MW and
with the hydrophobic-hydrophilic balance of the cationic polymers [80].
In a study by Yang et al. (2014), it was examined whether by converting the hydrophobic moiety
of a synthetic antimicrobial peptide (SAMP) into a hydrophilic one could provide hydrophilic cationic
polymer compounds with maintained antimicrobial activity, but enhanced biocompatibility and
selectivity for bacteria cells [73].
In this regard, not quaternary primary ammonium trifluoroacetate copolymers (SAMPs) were
prepared from N-(tert-butoxycarbonyl)aminoethyl methacrylate and butyl methacrylate. Then,
by replacing butyl methacrylate with 2-hydroxyethyl methacrylate (HEMA), hydrophilic cationic
mutants of previously prepared SAMPs were obtained.
The reactions were performed via AIBN-initiated free radical copolymerization or via
RAFT copolymerization. The so obtained BOC-protected copolymers, after deprotection with
trifluoroacetic acid provided the copolymer products [73]. Antibacterial assays showed that long
hydrophilic-and-cationic mutants of SAMPs were membrane active against bacteria but showed
strikingly reduced hemolytic toxicity and drastically enhanced selectivity [69,73].
Polymers, encompassing both tertiary amines groups protonable in a reversible way and permanent
protonated azetidinium moieties, were prepared by a simple two steps procedure [70]. Briefly,
waterborne multifunctional poly(vinylamine)s were first, prepared modifying commercial poly(vinyl
amine), through a reaction with functional cationic couplers, in order to improve its hydrophobicity.
Second, the modified poly(vinyl amine)s were furtherly functionalized by reaction with a bifunctional
coupler, thus inserting azetidinium groups and alkyl chains.
A library of cationic polymer compounds was achieved, whose structure-activity relations,
antimicrobial activities against Gram-positive and Gram-negative bacteria and hemolytic toxicity
were determined.
Finally, the best polymer was used to prepare antimicrobial cotton surfaces, which were tested on
E. coli establishing a 99.9% bacterial growth inhibition [70].
7.4. Polymers Containing Sulfonium Groups
Cationic polymers bearing sulfonium groups are similar to quaternary ammonium materials
in terms of charge, but few studies were performed for evaluating their antibacterial and/or
hemolytic activity.
In this regard, a study performed in 1990s reports the synthesis of poly(p-vinylbenzyl
tetramethylene sulfonium tetrafluoroborate salts with different MW values and the assessment
of their biocidal activity against S. aureus and E. coli in comparison to those of the corresponding
monomer [123].
The low MW monomer showed no activity against both the Gram-positive and Gram-negative
bacteria, while even if practically ineffective against E. coli, the polymer macromolecules, exhibited
acceptable antimicrobial activity, increasing with the increase of the MW, versus S. aureus.
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In particular, the best performant polymer (MW = 46,800) was able to kill all the bacterial cells
within 30 min at the concentrations of 100 and 10 µg/mL and was capable of destroying more than
99.9% of S. aureus cells at the lowest concentration of 1 µg/mL within 120 min of contact [123].
The sequence of events in the mode of action of sulfonium tetrafluoroborate polymers matched
the common mode of cationic biocides, which involves a phase of adsorption onto the bacterial OM,
followed by impairments of membrane integrity and diffusion through the cell wall.
A second phase of binding to the CM, followed by its disruption and release of cytoplasmic
constituents such as K+ ions, DNA and RNA up to cell death, follows.
As far as our knowledge allows, only another study dealing with sulfonium compounds with
antimicrobial activity was reported. Although it does not deal with polymeric materials but concerns a
library of 14 not polymeric low MW sulfonium salts, it has however reported. The prepared sulfonium
salts were evaluated both for their antimicrobial activity and biocompatibility and the results showed
that the major part of sulfonium salts proved higher biocompatibility and lower toxicity than those of the
less toxic compound among the ammonium and phosphonium salts, taken as references. Concerning
antimicrobial activity, the well performant compound was more active against S. aureus and B. subtilis
by 3–4 times if compared to the best ammonium and/or phosphonium salts, but less active versus E. coli
and P. aeruginosa by 5–8 times. Although sulfonium salts could be advisable as highly biocompatible
devices to counteract infections by Gram-positive bacteria, their clinical applications are limited by
their low thermal stability [124].
In this regard, the author suggest that the conversion of the best representatives of the reported
library in polymeric compounds could be an idea for both improving antibacterial effects and enhancing
stability of the small molecules.
7.5. Polymers Containing Heterocycles with Permanently Cationic Quaternized Nitrogen Atoms
A series of synthetic biodegradable polycarbonates containing propyl and hexyl halogenated side
chains were prepared via ring-opening polymerization (ROP) performed under an inert atmosphere in
a nitrogen-filled glovebox. Subsequently, they were quaternized under ambient laboratory conditions
with different heterocycles, such as methyl, ethyl and butyl imidazoles and pyridines. Alkyl imidazole,
as well as pyridine and dimethylamine pyridine (DMAP) polymer derivatives were achieved and were
investigated concerning their antimicrobial activity (MIC) against S. aureus, E. coli, P. aeruginosa and
C. albicans (fungus) [89].
In addition, hemolytic cytotoxicity (HC50) were assessed and the results were compared with
those from analogous polymer scaffolds quaternized with trimethylamine (TMA). All compounds,
TMA derivatives included, showed very low hemolytic toxicity, but concerning antimicrobial activity,
heterocyclic compounds proved higher activity than TMA macromolecules, especially against S. aureus.
However, remaining within the interests of this review, heterocyclic polymers proved higher
activity against E. coli and lower on P. Aeruginosa and hexyl derivatives both containing pyridine,
DMAP or alkyl-imidazole groups were the best performants and the MIC observed against E. coli were
< 4 µg/mL and in the range 31–63 and 8–31 µg/mL, respectively (Table 5) [89].
Studies concerning the mechanisms of action performed on E. coli confirmed the usual a-specific
disruptive action on bacterial cell membranes that assure a minor tendency to develop drugs resistance.
A copolymer of 4-vinylpyridine (4VP), styrene (St) and divinylbenzene (DVB), namely
P(4VP-St-DVB), was prepared by suspension polymerization and subsequently was quaternized
with excesses of halohydrocarbons (RX) such as benzyl bromide (BzBr), C4H9Cl, C4H9Br and C4H9I to
prepare series of insoluble pyridinium-type polymers, namely Q-P(4VP-St-DVB)-RX [46].
Living and death cells of E. coli, suspended in sterilized and distilled water, were the selected
candidates on which the capability of the prepared pyridinium CAPs of interacting and adhering
to bacteria cells wall was investigated, while living cells were used to evaluate their antimicrobial
properties by a colony count method [46].
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The results showed that, except for the compound containing iodine, insoluble pyridinium-type
polymers, were capable to imprison both living and death bacterial cells by a partially irreversible
adsorption or adhesion process, without killing the living cells. From these results, the cationic
polymers developed could be advisable for the treatment of waste waters [46].
A number of polymers, such as high-density polyethylene (HDPE), low-density poly ethylene
(LDPE), polypropylene (PP), nylon 6/6 and poly(ethylene terephthalate) (PET) were functionalized with
poly(vinyl-N-hexyl pyridinium bromide) (hexyl-PVP) obtaining quaternary pyridinium antimicrobial
surfaces whose antibacterial effects were essayed on S. aureus and E. coli.
Suspensions of bacteria in distilled water were sprayed on the hexyl-PVP-modified polymer
slides, to simulate airborne bacteria. The slides were incubated overnight and the results from the
counting of survived colonies showed that all polymers provided high bactericidal activity on contact,
managing to kill up to 99% of bacteria [47].
The proposed methodology is eligible to render numerous products bactericidal, with limited
costs, being the surfaces renewable by periodic washings.
Previously, the same authors was reported the same idea, by functionalizing glass slides with the
same hexyl-PVP and performing the same procedure. Antimicrobial quaternized pyridinium glass
surfaces were obtained, that proved to be able to kill on contact the 94%, > 99%, > 99.8% and > 99% of
S. aureus (ATCC, strain 33,807), S. epidermidis (wild type), P. aeruginosa (wild type) and E. coli (ZK 605),
respectively [48].
Unfortunately, their extensive applications are strongly limited by their poor water solubility,
low biocompatibility and high risk of skin irritation. In order to address these issues, it was reported
the preparation of more hydrophilic methacrylate-based copolymers with bactericidal activity and
biocompatibility higher than those of quaternized poly(vinylpyridine) [90].
As comonomers were used either biocompatible HEMA and poly(ethylene glycol) methyl ether
methacrylate (PEGMA). First, copolymers with different content of comonomers were prepared starting
from vinylpyridine, by radical polymerization.
Second, the copolymers were quaternized with hexylbromide.
Pathogenic E. coli (O157:H7) was treated with the copolymers, in order to assess their antimicrobial
effects and the results showed that several of the copolymers possessed antibacterial activity ∼20 times
greater than that of pure quaternized poly(vinylpyridine) homopolymer. Even if the evidences of
the study supported the hypothesis of good biocompatibility, the authors made no claim as to the
biocompatibility of these materials [90].
In the same year, Allison et al. (2007) studied the biocompatibility of analogous pyridinium
co-polymers by interaction with human red blood cells, to analyze hemolysis. The results showed that
blood compatibility does not depend on the length of PEG chain in copolymers containing PEGMA.
A critical weight ratio PEGMA/VP was determined which divide copolymers with no-hemolysis
activity from those with 100% hemolysis [125].
Later, the hemolytic cytotoxicity expressed as HC50, the minimum bactericidal concentrations
(MBC) determined by the ability of the antimicrobial materials to kill 106 colonies of E. coli O157 and
the selectivity for some of the quaternized poly(vinylpyridine) and poly(ethylene glycol) methyl ether
methacrylate copolymers, at different content of vinylpyridine (VP) [P(VP-co-PEGMA 1100)-HB] were
investigated [126].
In addition, biocompatibility was evaluated by cell viability assays performed on human intestinal
epithelial cells cultivated in vitro, that offer specific advantages over red blood cells (RBC) hemolysis
assays, as a measure of biocompatibility of these copolymers.
The results confirmed acceptable MBC values (70 µg/mL), associated to very low HC50
(10,000 µg/mL) and high cells viability (1000 µg/mL) and therefore both low hemolytic activity
and good selectivity and cells viability for P(VP-co-PEGMA 1100)-HB containing 50% VP.
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Copolymers containing < 50% VP were endowed with high biocompatibility and very low HC50,
but were ineffective as antimicrobials, while copolymers containing 75% and 90% VP were more
effective but endowed with very low biocompatibility and high EC50 [126].
The VP monomer was employed also to prepare poly(4-vinyl pyridine/poly(vinylidene fluoride)
(P4VP/PVDF) polymeric microbeads, by the phase inversion technique [91].
PVDF was used as filler to achieve beads with proper mechanical strength. N-alkylation of the
P4VP moieties was developed by using alkyl chains of different lengths, because known to be able
to affect the antibacterial efficacy of the pyridinium-type polymers based on their number of carbon
atoms [47,48].
Several P4VP/PVDF were achieved and were investigated for their antimicrobial efficacy against
both bacterial and fungal spores. E. coli and Aspergillus niger were the representative pathogens of the
two categories, respectively [91].
The pyridinium groups quaternized with C4–C10 alkyl chains proved the highest antimicrobial
activity by a membrane disruptive action and in particular an number of beads of 0.8 wt % killed
almost the 100% of pathogens within 20 min of an E. coli suspension of 105 CFU/mL.
A larger number of beads was necessary to kill A. niger spores at the same time, because of the
more resistant nature of the fungal wall. The developed antimicrobial beads are highly stable and
allows repeated applications, maintaining effective micro biocidal properties [91].
7.6. Quaternized Branched Polyethyleneimine Ammonium Salts
Polyethylenimine (PEIs) or polyaziridine are polymers in which the monomeric unit of the
N,N-diethylamine is repeated, forming compounds encompassing amine groups and C2 aliphatic spacers.
PEIs can be linear, branched or dendrimeric, the first ones containing all secondary amines, while
the others primary, secondary and tertiary amino groups.
They are produced on industrial scale, are commercially available and find applications in many
fields, due to their positively charged character [127].
Among the several applications, PEIs are reported to be an effective permeabilizer of the OM of
Gram-negative bacteria [51].
In this regard, the effect of commercial b-PEI (50 kDa) on the OM of representatives of Gram-negative
bacteria as E. coli, P. aeruginosa and S. typhimurium was investigated by evaluating the bacterial uptake of
l-N-phenylnaphthylamine, which is a hydrophobic probe indicating increased hydrophobic permeation
of the OM. The uptake was prominent at the low concentration of 20 µg/mL. In addition, PEIs were
able to sensitize the bacteria under study to the hydrophobic antibiotics as clindamycin, erythromycin,
fucidin, novobiocin and rifampicin, to the lytic action of the detergent SDS and concerning P. aeruginosa,
also to the non-ionic detergent Triton X-100. From the results, it was reported that PEIs showed to be a
potent permeabilizer of the OM of Gram-negative bacteria, even if it does not inhibit the growth of
bacteria to any significant extent [51].
On the contrary, alkylated quaternized PEIs attached to flat macroscopic surfaces and to
nanoparticles proved high bactericidal effects toward both Gram-positive and Gram-negative
pathogenic bacteria.
Concerning this, the findings regarding the antimicrobial properties of surfaces observed by
immobilizing quaternized alkyl polyvinylpyridinium salts onto coating glass and plastic slides were
extended to b-PEIs, used in place of PVP.
b-PEI (≥ 25 kDa) were first, attached to NH2-glass slides and to magnetic Fe3O4 nanoparticles
containing NH2 groups, then were either alkylated only with an alkyl bromide derivative or furtherly
methylated by reaction with iodomethane [52].
After a screening performed on S. aureus to detect the candidate suitable for further investigation,
the hexyl-PEI glass slides and NPs were tested against other airborne S. epidermidis, P. aeruginosa and
E. coli with promising results. The bactericidal efficiency versus Gram-negative bacteria of our interest
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was in the range 67%–74% for the devices containing only the C1–C18 alkyl chain and 95%–97% for the
furtherly methylated ones (Table 5) [52].
The year later, following an analogous synthetic pathway, the same authors immobilized 750 kDa
b-PEIs onto cotton, wool, nylon or polyester cloths and furtherly alkylated the PEIs-modified materials
with ethyl and methyl chains achieving permanently cationic PEIs-based textiles. Their micro biocidal
efficiencies were assessed towards airborne bacteria and fungi [53].
The promising results showed that micro biocidal efficiency against E. coli was in the range
96%–99%, whereas versus P. aeruginosa in the range 97%–98%.
Heine and co-workers reported the synthesis of two kinds of amphiphilic compounds (series B-I
and B-II) and then the preparation of three kinds of amphiphilic poly(ethylene imine)s (series PEI-I,
PEI-II and PEI-III) randomly linked to cationic and hydrophobic groups (PEI-I), to compounds of series
B-I (PEI-II) and to compounds of series B-II (PEI-III).
In particular, compounds B-I encompass alkyl chains directly attached to the cationic group, while
compounds B-II have the cationic group and the alkyl chains connected by a spacer [92].
All compounds B-I and B-II and modified PEI polymers were tested to evaluate their antibacterial
properties against Bacillus subtilis, S. aureus and E. coli, while the more active were selected to investigate
the hemolytic toxicity. Concerning amphiphilic compounds, the highest activity against E. coli of our
interest, was showed by two compounds of B-I type having C14–C18 chains (MIC = 8 and 10 µg/mL),
but while the most active was hemolytic at concentration far higher than MIC (EC50 = 22 µg/mL),
the other showed an EC50 lower than MIC (4 µg/mL).
The most active among compounds of B-II type similarly possessed C14–C18 chains and showed a
higher MIC of 20 µg/mL and an EC50 = 28 µg/mL.
Polymer materials were less active than amphiphilic compounds and showed higher hemolytic
toxicity. On E. coli, PEI-II polymers were the most active (MIC of 60–100 µg/mL) but were also the most
toxic for red blood cells (EC50 << 1 µg/mL) [92].
8. Molecular Changes Caused by Cationic Antimicrobial Polymers: A Study Performed
The modality of interactions between CAPs and bacterial membranes was investigated by using
artificial lipid bilayers for simulating the permeability barrier of cell membranes and several linear
cationic polyelectrolytes, such as ammonium polybases (polylysine, polyallylamine, poly(ethylenimine)
(PEI)) and quaternary ammonium polysalts (polyionenes, quaternized poly(vinylpyridine) (PVP)).
When the models of lipid membranes were exposed to cationic polymers, revealed common scenarios.
After the formation of interface complexes between the negatively charged groups of lipid molecules
and proteins of the membranes and free cationic groups of positively charged polymers happens,
a translocation of the negatively charged molecules of lipids from the inside to the outside of the
membrane (“flip–flop” effect) and a lateral segregation of the negatively charged lipids, occur [128].
In a study by Timofeeva et al. (2009), TEM images of the E. coli treated with aqueous solutions of a
CAP, confirmed the mechanism involving membrane-disrupting action. In particular, the morphologic
changes in the bacteria involved OM, CM, cytoplasm, ribosomes and nucleoid [79].
9. Main Factors Influencing the Antimicrobial Properties and Cytotoxic Activities of CAPs
The substantial bactericidal efficiency of a CAP can be related to the polymerization degree, to
its hydrophobic mass, to the enlargement of the polymer coil and to the absolute number of active
cationic centers on a single polyelectrolyte molecule.
In this contest, the cooperative properties of the cationic polymer molecule, which are responsible
for strengthening its adsorption ability, binding affinity and destructive interaction with the bacteria
cell, are the pivotal factors that influence its bactericidal effect.
The MW, the cationic charge density, the type of counterion, the global hydrophobicity and the
hydrophilic–lipophilic balance (HLB) are the factors that profoundly impact the efficacy of many CAPs.
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It was reported that an optimal MW ranges from 50 to no more than 100 kDa [79], even if in some
cases the biocidal effect of some CAPs versus particular bacteria enhances incessantly with the growth
of MW. In this regard, Ikeda et al. have indicated that adsorption ability and capability to penetrate
through OM/CM are the key factors that control antimicrobial activity of CAPs [129].
In addition, the presence of alkyl groups may influence the antimicrobial efficacy of CAPs based
on the length of the alkyl hydrocarbon chains. With the elongation of alkyl chains, the polymer
behavior changes and, though its adsorption/absorption ability and lipophilicity result improved,
variations in the HLB could modify CAP ability in counteract different microorganisms. It can be
assumed, that different optimal alkyl appendage lengths for different macromolecular systems are
necessary to achieve higher antimicrobial efficacy against a given type of microorganism.
Examples of variations in the antimicrobial activity of some CAPs, in function of variations in
MW and alkyl chains length, were reported in Table 6.
Table 6. Variations in the antimicrobial activity of some CAPs in function of variations in MW and
alkyl chains length.
Type of CAPs MW (Da) Alkylation Antimicrobial Activity
oligomeric guanidinium ↓MW ↓activity [130]
quaternized
N-hexyl-PVP, immobilized on a surface 160,000 full bactericidal effect [131]
quaternized N-hexyl, N-methyl-PEI
immobilized on a surface 25,000 full bactericidal effect [131]
quaternized poly(2-(dimethylamino)ethyl
methacrylate) (PDMEMA) Mn >10,000 100% killing efficiency [110]
secondary and tertiary












not influenced by the length
of the alkyl substituents at
the nitrogen [132]
alkylated quaternized PVP polymers alkyl > C6 chain ↓activity [133]
quaternized poly (4-vinyl pyridine)
(P4VP)-poly (vinylidene fluoride)
(PVDF) co-polymer
C4>chain< C10 ↑activity [134]
quaternized alkyl pyridinium
polyoxanorbornene Chain < C4 minimal activity [88]
quaternized alkyl pyridinium
polyoxanorbornene Chain > C6 ↑activity [88]
As reported [134], the spatial separation of the positive charge and the presence of hydrophobic
alkyl side chains, may influence both the antimicrobial properties and the hemolytic and cytotoxic
effect to human cells. In particular, higher membrane-disrupting ability was observed when the charge
is spatially separated from the alkyl chain [134].
Consequently, on one hand the antibacterial activity was improved, but on the other hand, also
the hemolytic activities and toxicity on mammalian cells resulted increased.
In another study, it was reported that, the antimicrobial activity against E. coli and S. aureus, as well
as the biocompatibility of methacrylamide-based random copolymers depend, in a different manner,
on the mole fraction of the alkyl side chains and their length, but are strictly correlated to the content
in primary amine groups, thus evidencing the membrane-disrupting action of the co-polymers [121].
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In this contest, other examples of correlations between polymers structural properties and
antimicrobial activity/toxicity were reported in Table 7.
Table 7. Correlations between polymers structural properties, antimicrobial activity and toxicity.
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cationic PDAAs containing pyrrolidine
links
protonated secondary or
tertiary amine groups not available ↑ [136]




groups not available ↑ [79]
poly(diallylammonium trifluoroacetate)
(PQAS TFA) quaternary ammonium groups not available ↓ [79]
1
quaternized alkyl pyridinium
polyoxanorbornene chain < C4 low ↓ [88]
quaternized alkyl pyridinium
polyoxanorbornene chain > C6 considerable ↑ [88]
1 compared to the not quaternized polymers reported in the previous row.
As described in Table 5 and in Sections 6 and 7, several of the antimicrobial cationic
polymers developed, have proved good biocompatibility and low or even absent hemolytic toxicity.
The explanation of a certain selectivity for bacteria cells resides in the different lipid composition of
pathogen cell wall and of mammalian cell membranes. While bacterial membranes contain lipids
with net anionic charge and no cholesterol, eukaryote membranes encompass zwitterionic lipids
and cholesterol.
In particular, the membrane of eukaryotic cells is made of cholesterol (up to 25%), phosphatidylcholine
lipids and an essentially zwitterionic neutral outer leaflet [137].
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Differently, the membranes of Gram-negative bacterial cells do not contain cholesterol, have low
levels of zwitterionic lipids as phosphatidylethanolamine and contain considerable levels of negatively
charged lipids including phosphatidylglycerol, cardiolipin (20%–25%) and LPS. In this regard, cationic
antimicrobials are rationally more promptly attracted by the strong negativity of bacterial OM and
are readily inserted into bacterial lipid mixtures, rather than by the neutral membrane of mammalian
cells [137].
Interestingly, no insertion of cationic materials was detected in the model of “mammalian”
membranes used for experiments and no toxicity was observed [137].
In addition, it was established that cholesterol, which is present in mammalian cells, but absent in
bacterial membranes, play a pivotal role in limiting or hampering the CAPs penetration, by acting as a
“protectant” [137].
10. Conclusions and Perspectives
The incidence of multidrug resistant Gram-negative infections are one of the emerging problems
that disturbs several human activities and life sectors such as food industry, food processing,
transportation and healthcare services. Gram-negative bacteria cause infections including pneumonia,
bloodstream infections, wound or surgical site infections and meningitis above all in healthcare
settings. The concern associated to Gram-negative infections is destined to increase in importance,
as traditional therapeutic remedies have become limited. Nowadays, Gram-negative bacteria are
resistant to multiple drugs due to built-in abilities, which over the years have make them able to
find new ways to be resilient and to pass genetic materials that enabled other bacteria to become
drug-resistant as well. The well-known cephalosporins, fluoroquinolones and carbapenems gradually
have turned out to be ineffective with the result of a worrying higher mortality rate across the world.
Aggressive recommendations, if implemented, can prevent the spread of Gram-negatives, but in order
to actually address this issue, it is necessary to identify probable novel lead molecules to combat
these infections.
Natural cationic antimicrobial peptides (CAMPs), as polymyxins, possess high activity versus
alarming bacteria as multi-drugs resistant Gram-negative Klebsiella spp., Acinetobacter spp., P. aeruginosa
and E. coli but, in addition to be high-costly and unstable, are too toxic for human cells for being
extensively used in clinical applications. On the example of CAMPs, in the last decades and up today,
researchers’ efforts were and are focused on the synthesis of less toxic compounds that mimic AMPs,
in terms of mechanism of action and effectiveness. Synthetic cationic compounds and antimicrobial
peptides were developed and essayed with promising outcomes.
In this challenge, polymers have gained increasing attention by the scientific community,
as promising materials to prepare antimicrobial agents, because differently from small drug molecules,
they could be endowed with more long-term activity, limited residual toxicity, chemical stability,
non-volatility and incapacity to permeate through the skin thanks to its macromolecular structure and
high MW.
Starting from these observations, cationic polymeric materials encompassing the main structural
features of CAMPs, mimicking their a-specific mechanism of actions, based on the disruption of OM
and CM and able to kill rapidly bacteria on contact, were developed.
Although the pending issue of hemolytic toxicity and biodegradability of cationic polymeric
materials is still left not completely solved, these macromolecules possess a higher affinity towards
the anionic membrane of bacteria and a reduced toxicity toward eukaryotic cells, have low tendency
to develop resistance and could have a decisive role in the global effort to find effective solutions for
counteracting resistant Gram-negative bacteria.
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However, although the scientific advances achieved during the last years are encouraging, further
research work both in vitro and in vivo, is mandatory to enhance the antimicrobial activity versus
more strains of bacteria, to increase the long-term stability, to nullify the residual toxicity, to develop
cost-effective solutions and to allow a more extensive clinical application.
In the opinion of the authors, among the profuse production of CAPs, the compounds containing
guanidine or bi-guanidine residues appear as the materials that best find an optimal compromise
between good antimicrobial activity, low hemolytic toxicity and good biocompatibility.
Considering the performances shown by guanidinium antimicrobial polymers already prepared
and bearing in mind the incomparable properties of dendrimers, already widely used in the biomedical
field, a promising new strategy could be to prepare biodegradable dendrimers functionalized with
guanidine residues, with heterocycles having nitrogen atoms with characteristics similar to those of
guanidine such as imidazole or with biocompatible molecules containing such residues as arginine
and histidine.
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